Pfizer: A High-Yield Pharma At A Turning Point
Source: SeekingAlpha
2026-01-29 09:00:00 ET
Since my November article , "Pfizer: Is This Pharma Giant Finally A Bargain", Pfizer stock ( PFE ) has risen 5.6%, outperforming the 'barometer' for the biotech investors, the iShares Biotechnology ETF ( IBB ) [5.2% return], as well as the S&P 500 (SPY) [5%]....
Read the full article on Seeking Alpha
For further details see:
Pfizer: A High-Yield Pharma At A Turning Point
iShares Biotechnology ETF
NASDAQ: IBB
IBB Trading
2.34% G/L:
$173.40 Last:
562,032 Volume:
$172.12 Open:
